In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.
molekuul.be/Stock.adobe.com
Microfluidic modulation spectroscopy (MMS) is a novel automated infrared spectroscopic technique with high sensitivity and repeatability. Here, the authors present a series of experimental studies showcasing the performance of MMS in the secondary structure characterization of biopharmaceutical products and compare the MMS results with the conventional Fourier transform infrared data.
Click
herefor a PDF of the article.
Submitted: Dec. 9, 2019
Accepted: March 9, 2020
Dipanwita Batabyal*, dbatabya@amgen.com, is scientist at Attribute Sciences-Higher Order Structure Group, Amgen, and Mats Wikström*, matsw@amgen.com, is principal scientist at Higher Order Structure, BR&C, Attribute Sciences, Amgen. Libo Wang is principal application scientist and Jeffrey Zonderman is chief commercial officer at RedShift Bioanalytics.
*To whom correspondence should be addressed.
BioPharm International
Vol. 33, No. 5
May 2020
Pages: 42–47
When referring to this article, please cite it as F. Mirasol, “Shaping IR Spectroscopy into a Powerful Tool for Biopharma Characterizations,” BioPharm International 33 (5) 2020.
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.